![]() | |||||
lose weight | |||||
NEWS | |||||
Adults with obesity lost 22.7% of body weight with combination GLP-1/amylin analog Key takeaways: CagriSema induced superior weight loss compared with placebo for adults with obesity in the REDEFINE 1 trial. The medication's safety ...
| |||||
Older, cost-effective anti-obesity medications maintain weight loss after GLP-1 therapy Participants enrolled in a GLP-1 receptor agonist weight-loss program maintained their weight loss at long-term follow-up after transitioning to ...
| |||||
See more results | Edit this alert |
You have received this email because you have subscribed to Google Alerts. |
![]() |
Send Feedback |